Showing papers by "Lawrence D. True published in 1992"

TL;DR: The discovery of recurrent cancer following radical retropubic prostatectomy in a man who had undetectable serum PSA levels suggests that careful clinical monitoring remains essential after definitive therapy, since rare patients may have recurrent and/or residual carcinoma despite undetECTable levels of PSA.